Core Insights - Aflac Incorporated (AFL) is scheduled to report its fourth-quarter 2025 results on February 4, 2026, with earnings estimated at $1.71 per share and revenues at $4.48 billion [1] Earnings Estimates - The fourth-quarter earnings estimate has decreased by $0.01 over the past month, but still reflects a year-over-year increase of 9.6%. Quarterly revenues are projected to grow by 3.8% year-over-year [2] - For the full year 2025, Aflac's revenue estimate stands at $17.72 billion, indicating a decline of 0.6% year-over-year, while the EPS estimate is $7.63, suggesting a growth of 5.8% year-over-year [3] Earnings Prediction Model - The current model does not predict an earnings beat for Aflac, as it has an Earnings ESP of -3.12% and a Zacks Rank of 4 (Sell) [4] Factors Influencing Q4 Results - Aflac is expected to report Q4 EPS of $1.71 on $4.48 billion revenue, indicating 9.6% earnings growth and 3.8% sales growth. Net earned premiums are anticipated to rise by 3%, with U.S. revenues increasing by 5.1% and Japan by 1% [7] - The total benefit to premium ratio for Aflac Japan is projected at 64.7, down from 66.5 a year ago, with a 3.4% growth in pre-tax adjusted earnings. However, the U.S. benefit to premium ratio is expected to rise to 48.9 from 46.3, with a projected 7.1% decline in pre-tax adjusted earnings [9] - Aflac's net investment income is expected to decline by 5% year-over-year, which may offset some positive factors, making an earnings beat uncertain [10] Peer Performance - Marsh & McLennan reported Q4 adjusted EPS of $2.12, exceeding estimates by 7.6% due to growth in Risk and Insurance Services [11] - Aon reported Q4 adjusted earnings of $4.85 per share, surpassing estimates by 1.9%, driven by organic revenue growth and high retention rates [12] - Hartford Insurance reported Q4 adjusted operating earnings of $4.06 per share, exceeding estimates by 27.9%, supported by higher net investment income and improved loss ratios [13]

Analysts on Wall Street project that Aflac (AFL) will announce quarterly earnings of $1.71 per share in its forthcoming report, representing an increase of 9.6% year over year. Revenues are projected to reach $4.48 billion, increasing 3.8% from the same quarter last year.Over the last 30 days, there has been a downward revision of 1.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over ...

The market expects Aflac (AFL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on F ...

Core Insights - Albert Anthony is a Croatian-American business author and analyst contributing to Seeking Alpha with over 1,000 followers [1] - He has authored a book titled "Real Estate Investment Trusts (REITs): A Fundamental Analysis (2026 Edition)" available on Amazon [1] - Anthony has a background in business and information systems, having worked at Charles Schwab in the IT department [1] - He operates his own equities research firm, Albert Anthony & Company, remotely from Texas [1] - The author has participated in numerous business and innovation conferences and has hosted a program for Online Live TV Croatia [1] - He holds a B.A. in Political Science and various certifications including Microsoft Fundamentals and Risk Management specialization from CFI [1] - Anthony is also active on YouTube discussing REITs, reflecting his personal investment interests [1] Company and Industry Summary - Albert Anthony & Company is a Texas-registered boutique equities research firm managed entirely by Anthony [1] - The firm focuses on providing general market commentary and research based on publicly available data [1] - The author does not engage with non-publicly traded companies, small cap stocks, or startup CEOs, indicating a focus on established market entities [1] - The firm does not provide personalized financial advisory services or manage client funds, emphasizing a research-oriented approach [1]

Core Insights - Aflac Incorporated (AFL) has announced a strategic partnership with Workday Wellness to integrate its supplemental health solutions into the Workday platform, enhancing employer benefits offerings through AI-driven insights [1][8] Group 1: Partnership and Platform Overview - Workday Wellness is an AI-driven platform that provides real-time insights into employee benefits and wellness programs, aimed at improving administrative efficiency and engagement [2] - The partnership addresses a significant challenge in employee benefits, as highlighted by the 2025-2026 Aflac Workforces Report, which indicates that many employees lack understanding of their benefit options [3][4] Group 2: Benefits of the Partnership - The integration of Aflac's supplemental health solutions into Workday Wellness is expected to increase customer satisfaction and utilization of Aflac's products, potentially attracting new customers and retaining existing ones [5] - Aflac's supplemental products offer financial protection against out-of-pocket expenses not covered by primary insurance, including a variety of offerings such as cancer, accident, and critical illness insurance [6] Group 3: Market Performance - Aflac's shares have increased by 8.1% over the past six months, outperforming the industry growth of 6.3% [7]

Core Insights - Aflac has been named a strategic Workday Wellness partner, allowing integration of its supplemental health products with Workday Wellness to enhance employer benefit offerings and streamline administration [1][2] Company Overview - Aflac is a leading provider of supplemental health insurance in the U.S. and has been recognized for its ethical practices and sustainability efforts, being included in the World's Most Ethical Companies for 19 consecutive years and Fortune's Most Admired Companies for 24 years [5] Partnership Benefits - The partnership with Workday Wellness aims to provide AI-driven recommendations for employers, improving the agility and responsiveness of benefit offerings [2] - Workday Wellness offers real-time insights into employee benefits usage, enhancing administrative efficiency and engagement for both employers and employees [2] Employee Engagement - According to the 2025-2026 Aflac Workforces Report, a significant number of employees desire more information about their benefits, with nearly half not fully understanding their policies, which may lead to underutilization [3] - Aflac emphasizes that better understanding of benefits can increase their usage and appreciation among employees, highlighting the importance of effective communication in employee benefits solutions [4]

Group 1: Company Overview - Aflac Incorporated (NYSE:AFL) is recognized as one of the 14 Best Dividend Growth Stocks to Buy and Hold in 2026 [1] - Aflac provides financial protection products through its subsidiaries, primarily operating in the United States and Japan [4] Group 2: Financial Performance and Analyst Ratings - TD Cowen raised its price target on Aflac to $102 from $100 while maintaining a Hold rating on the shares following a review of the company's third-quarter results [2] Group 3: Cybersecurity Incident - In June, Aflac disclosed a cyberattack that compromised customer data, later confirming that approximately 22.65 million individuals were affected [3] - The stolen information included sensitive data such as names, birthdates, home addresses, Social Security numbers, and medical details [4] - Aflac has begun notifying affected individuals and is providing support resources, stating that it is not aware of any fraudulent use of the compromised personal information [4]

Core Viewpoint - Aflac Incorporated is set to release its fourth quarter 2025 financial results on February 4, 2026, with a subsequent conference call scheduled for February 5, 2026, to discuss these results and answer questions from investors [1][2]. Company Overview - Aflac Incorporated is a Fortune 500 company that has provided financial protection for over seven decades to millions of policyholders through its subsidiaries in the U.S. and Japan [3]. - In the U.S., Aflac is the leading provider of supplemental health insurance products, while in Japan, Aflac Life Insurance Japan is the top provider of cancer and medical insurance based on policies in force [3]. - The company has been recognized for its ethical practices, being included in the World's Most Ethical Companies by Ethisphere for 19 consecutive years and Fortune's World's Most Admired Companies for 24 years [3]. - Aflac became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been part of the Dow Jones Sustainability North America Index for 11 years [3].

Core Viewpoint - Investing in Dividend Aristocrats provides solid dividend growth from established businesses that have successfully navigated multiple business cycles [1] Group 1 - Dividend Aristocrats are companies known for their consistent and reliable dividend payments [1] - These companies have a proven track record of enduring various economic conditions, making them a stable investment choice [1] - The strategy of investing in Dividend Aristocrats can help anchor an investment portfolio [1]

Core Viewpoint - Aflac Incorporated (AFL) is positioned for growth due to strong U.S. business performance, product launches, acquisitions, partnerships, improved underwriting discipline, and effective cost management [2] Financial Performance - Aflac's shares have increased by 4.7% over the past six months, outperforming the industry's 2.8% rise [2] - The market capitalization of Aflac is $58.1 billion [2] - The Zacks Consensus Estimate for AFL's 2025 earnings is $7.53 per share, reflecting a 4.4% year-over-year increase [4] - Revenue estimates for 2025 are projected at $17.8 billion [4] - Aflac has beaten earnings estimates in two of the last four quarters, with an average surprise of 9.4% [4] Growth Drivers - Aflac's revenue growth is supported by strong sales in both U.S. and Japan segments, driven by strategic investments and high persistency rates [5] - New annualized premium sales in Aflac Japan grew by 16.1% year-over-year in the first nine months of 2025, primarily due to sales of the Miraito cancer insurance product and Tsumitasu [5] - Aflac U.S. saw a 3% year-over-year increase in new annualized premium sales in the first nine months of 2025, with group products contributing significantly [6] - The company is enhancing its core insurance growth through strategic acquisitions and partnerships, expanding its capabilities and reach [7] Financial Position - Aflac concluded the third quarter of 2025 with $6.8 billion in cash and cash equivalents, an increase from $6.2 billion at the end of 2024 [8] - The company maintains a strong times-interest-earned ratio of 25.39X, compared to the industry average of 20.02X [8] - Aflac has prioritized shareholder rewards, repurchasing 25.7 million shares worth $2.7 billion in the first nine months of 2025 [8]